Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Both treatments for alopecia areata showed similar modest effectiveness.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Allergies and atopic conditions may increase the risk of developing alopecia areata.